Navigation Links
Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD
Date:11/1/2010

HUDDINGE, Sweden, November 1, 2010 /PRNewswire/ -- Medivir AB (OMX:MVIR), the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily. The study was conducted in treatment-naive patients with chronic genotype 1 Hepatitis C virus (HCV) and is part of a late-breaker oral presentation at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA.

Highlights of the data: - 79% to 86% of patients were able to stop all therapy at week-24 - No relevant differences for adverse events between TMC435 treatment groups and placebo

Commenting on the announcement by Medivir's development partner, Tibotec, Ron Long, Chief Executive of Medivir, said: "We are very pleased to have such exciting TMC435 data presented by our partner, Tibotec, at the AASLD. The data announced shows the significant impact that TMC435 could have on the way we treat hepatitis C."

Please note that Medivir will be hosting meetings for Investors, Analysts and the Media at the AASLD (see end of press release).

Tibotec released the following statement on the results on Saturday 30th October:

Week 24 interim results from phase 2b PILLAR study to be presented as late-breaker at AASLD

-- Data show high antiviral activity, safety and tolerability comparable to placebo

Boston, MA. Saturday 30th October 2010 - Tibotec Pharmaceuticals (Tibotec) today will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) as part of a late-breaker oral presentation at the
'/>"/>

SOURCE Medivir
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Medivir Interim Report, 1 January - 30 September 2010
2. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
3. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
4. Cord Blood America Continues to Reduce Debt; Three Notes Retired
5. Par Pharmaceutical Announces Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
6. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest
7. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
8. Quest Diagnostics Commences Cash Tender Offer for Any and All of Certain of its Outstanding Notes
9. Stryker Corporation Announces Pricing of Senior Notes
10. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
11. Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CHESTERBROOK, Pa. , July 31, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today ... million regulatory milestone payment from its partner Asahi ... due because of the successful submission of a ... Device Agency (PMDA) for XIAFLEX ® (collagenase ...
(Date:7/31/2014)... , 31 juli 2014 De Pfizer Clinical ... rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor medewerking ... gevestigde PCRU is één van twee onderzoekseenheden ... ideaal levens te verbeteren door de ontdekking en ontwikkeling ... PCRU op zoek naar mannen en vrouwen van Japanse ...
(Date:7/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ) today announced ... 28, 2014. Third Quarter Financial Highlights and ... million, reflecting operational growth of 0.5% and a positive ... in the prior year. , Revenues grew in ... revenues grew 3.5%. , GYN Surgical revenues grew ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
... PITTSBURGH , July 14 D3 Radiation Services announced ... service designed to reduce errors in the delivery of radiation therapy--as a ... , , , ... participating clinics and radiation oncology physicists can order a comprehensive audit of ...
... PITTSBURGH , July 14 Mylan Inc. ... Matrix Laboratories Limited has received final approval from the ... New Drug Application (ANDA) for Nabumetone Tablets USP, 500 ... be bioequivalent and, therefore, therapeutically equivalent to Nabumetone Tablets, ...
Cached Medicine Technology:eDataAudit Receives Approval from the American Board of Radiology 2Mylan Receives Approval for Nabumetone Tablets 2
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- A new report ... made to their doctor,s office involved diabetes, with the greatest ... the U.S. Centers for Disease Control and Prevention found the ... age group jumped by 34 percent between 2005 and 2010. ... and managing the blood sugar disease costs almost $245 billion ...
(Date:7/31/2014)... Kansas City, MO (PRWEB) July 31, 2014 ... recently recognized with an Excellence Through Insight award for ... Healthcare Providers and Systems (CG-CAHPS) database in multiple categories ... honor for their commitment to excellence in patient care. ... must have been a patient satisfaction-tracking client of HealthStream ...
(Date:7/31/2014)... 2014 With the brand change comes more ... lecture series featuring the “reality model” used by Franklin ... more affordable resort pricing structure, and a renewed focus on ... have always had a great weight loss program, we really ... Ridge. We want to change the way people feel about ...
(Date:7/31/2014)... previously linked to cognitive impairment in older adults ... according to investigators from the Regenstrief Institute, ... University of East Anglia and several other United ... more than a decade of studies on the ... that these drugs have a significant adverse effect ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 RankingBySEO, a ... for those individuals and organizations against whom negative reviews ... ‘Remove Negative Comments Service’. , About the service, ... have officially announced the service now, but we have ... of negative comments for several years.” , On being ...
Breaking Medicine News(10 mins):Health News:Big Jump in Doctor's Office Visits for Young Adults With Diabetes 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Weight Loss Destination, the Biggest Loser Resort in Utah, Rebrands as Fitness Ridge 2Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2
... 24 (HealthDay News) -- Morbidly obese patients who undergo spinal ... and also face higher hospital costs, a new study says. ... spinal pain. People with a body mass index (BMI) of ... generally 50 to 100 percent over their ideal body weight, ...
... , WEDNESDAY, May 23 (HealthDay News) -- The risk of ... travel more slowly through the lower chambers of the heart, ... heart and cause it to pump blood through its four ... be measured using an electrocardiogram (ECG). The waves traveling through ...
... the most comprehensive analyses to date of the cost of ... that this now-dominant surgical approach is significantly more costly than ... patient outcomes. The results of the study are available online ... Urology . In one of the first ...
... that maintain healthy nerve connections as we age help keep ... charity Age UK has found. Older people with robust ... different, distant brain areas can process information quickly and ... According to the findings, joining distant parts of the ...
... , WEDNESDAY, May 23 (HealthDay News) -- The ... reduced through a multi-pronged approach that includes more training ... to a new German study. Despite legal regulations ... as bed rails and belts still are frequently used ...
... Minn. -- Mayo Clinic researchers will present findings on ... at the annual meeting of the American Urological Association ... be available to provide expert comment for reporters covering ... presented and their embargo dates include: No ...
Cached Medicine News:Health News:Severely Obese Have More Complications With Spinal Surgery 2Health News:Study Spots Early Warning Signal for Sudden Cardiac Death 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The uncemented hip joint prosthesis system...
Medicine Products: